|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
|
|---|---|---|---|---|
| Assets | ||||
| Accounts receivable | ||||
| Cash and cash equivalents | ||||
| Trade receivables | ||||
| Other receivables | ||||
| Inventory | ||||
| Prepaid expenses | ||||
| Total Current Assets | ||||
| Intangible assets | ||||
| Property and equipment | ||||
| Total Assets | ||||
| Trade payables and accrued liabilities | ||||
| Related Parties | ||||
| Deferred revenue | ||||
| Enhanced voting preference shares | ||||
| Derivative for settlement agreement | ||||
| Long term loan – current portion | ||||
| Total Current Liabilities | ||||
| Long term loan | ||||
| Warrants | ||||
| Derivative warrants liabilities | ||||
| Liabilities for employee benefits | ||||
| Total Liabilities | ||||
| Shareholders’ Equity | ||||
| Value of shares issued | ||||
| Shares to be issued | ||||
| Share-based payment reserve | ||||
| Translation differences reserve | ||||
| Capital reserve for re-measurement of defined benefit plan | ||||
| Accumulated Deficit | ||||
| Total Shareholders’ equity | ||||
| Total Liabilities and Shareholders’ Equity | ||||
Loading...
